These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2509904

  • 1. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver.
    Matsuoka H, Aji T, Ishii A, Arimoto S, Wataya Y, Hayatsu H.
    Mutat Res; 1989 Nov; 227(3):153-7. PubMed ID: 2509904
    [Abstract] [Full Text] [Related]

  • 2. Modified metabolism of a carcinogen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), by liver S9 from Schistosoma japonicum-infected mice.
    Arimoto S, Matsuoka H, Aji T, Ishii A, Wataya Y, Hayatsu H.
    Mutat Res; 1992 Jul; 282(3):177-82. PubMed ID: 1378550
    [Abstract] [Full Text] [Related]

  • 3. Retention of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), in the liver of mice infected with Schistosoma japonicum.
    Aji T, Matsuoka H, Ishii A, Arimoto S, Hayatsu H.
    Mutat Res; 1994 Mar 01; 305(2):265-72. PubMed ID: 7510037
    [Abstract] [Full Text] [Related]

  • 4. Developmental changes in hepatic activation of dietary mutagens by mice.
    Brennan-Craddock WE, Neale S, Mallett AK, Rowland IR.
    Chem Biol Interact; 1989 Mar 01; 71(4):367-79. PubMed ID: 2510945
    [Abstract] [Full Text] [Related]

  • 5. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
    Gentile JM, Brown S, Aardema M, Clark D, Blankespoor H.
    Arch Environ Health; 1985 Mar 01; 40(1):5-12. PubMed ID: 3922319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation.
    De Flora S, Bagnasco M, Bennicelli C, Camoirano A, Bojnemirski A, Kurelec B.
    Mutagenesis; 1995 Jul 01; 10(4):357-64. PubMed ID: 7476273
    [Abstract] [Full Text] [Related]

  • 10. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM, DeRuiter E.
    Toxicol Lett; 1981 Jul 01; 8(4-5):273-82. PubMed ID: 6791314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K, Maeda K, Kamataki T, Kato R.
    Mutat Res; 1986 Jun 01; 174(2):85-8. PubMed ID: 3086716
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of hepatic cytochrome P-450 inducing agents on mutagen activity in the host-mediated assay.
    Alldrick AJ, Brennan-Craddock WE, Lake BG, Rowland IR.
    Mutat Res; 1992 Aug 01; 268(2):307-14. PubMed ID: 1379336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.